CYAN Stock Overview
An agricultural company, engages in the production of natural products derived from microalgae worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Cyanotech Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.38 |
| 52 Week High | US$0.96 |
| 52 Week Low | US$0.12 |
| Beta | -0.094 |
| 1 Month Change | 9.44% |
| 3 Month Change | -45.81% |
| 1 Year Change | -56.82% |
| 3 Year Change | -87.86% |
| 5 Year Change | -83.41% |
| Change since IPO | -62.00% |
Recent News & Updates
Recent updates
Cyanotech Corporation (NASDAQ:CYAN) Not Doing Enough For Some Investors As Its Shares Slump 39%
Feb 15
Is Cyanotech (NASDAQ:CYAN) Using Debt Sensibly?
Feb 09Is Cyanotech (NASDAQ:CYAN) Weighed On By Its Debt Load?
Oct 05There's Been No Shortage Of Growth Recently For Cyanotech's (NASDAQ:CYAN) Returns On Capital
Sep 30Here's Why Cyanotech (NASDAQ:CYAN) Can Manage Its Debt Responsibly
Aug 14Cyanotech GAAP EPS of -$0.08, revenue of $6.72M
Aug 10Cyanotech (NASDAQ:CYAN) Might Have The Makings Of A Multi-Bagger
Jun 08Is Cyanotech (NASDAQ:CYAN) A Risky Investment?
May 12The ESG Future Of Food Protein Production: Cyanotech
Mar 19Cyanotech (NASDAQ:CYAN) Is Doing The Right Things To Multiply Its Share Price
Mar 04We Think Cyanotech (NASDAQ:CYAN) Can Stay On Top Of Its Debt
Jan 11Cyanotech (NASDAQ:CYAN) Is Experiencing Growth In Returns On Capital
Nov 30Cyanotech (NASDAQ:CYAN) Is Carrying A Fair Bit Of Debt
Jun 08Cyanotech's (NASDAQ:CYAN) Promising Earnings May Rest On Soft Foundations
Feb 23These 4 Measures Indicate That Cyanotech (NASDAQ:CYAN) Is Using Debt Reasonably Well
Feb 08
Returns On Capital Tell Us A Lot About Cyanotech (NASDAQ:CYAN)
Jan 04Cyanotech Corporation's (NASDAQ:CYAN) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Nov 30Cyanotech reports Q2 results
Nov 12Shareholder Returns
| CYAN | US Personal Products | US Market | |
|---|---|---|---|
| 7D | -5.0% | 0.4% | 2.8% |
| 1Y | -56.8% | -25.5% | 24.6% |
Return vs Industry: CYAN underperformed the US Personal Products industry which returned -25.6% over the past year.
Return vs Market: CYAN underperformed the US Market which returned 24.5% over the past year.
Price Volatility
| CYAN volatility | |
|---|---|
| CYAN Average Weekly Movement | 30.4% |
| Personal Products Industry Average Movement | 8.3% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 17.4% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: CYAN's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: CYAN's weekly volatility (30%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | 77 | Matt Custer | www.cyanotech.com |
Cyanotech Corporation, an agricultural company, engages in the production of natural products derived from microalgae worldwide. The company offers BioAstin Hawaiian Astaxanthin, a natural antioxidant to enhance skin, and to support eye, joint and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement to support natural energy, immune system, and cardiovascular health, as well as a source of antioxidant carotenoids. It also provides contract extraction and research and development services.
Cyanotech Corporation Fundamentals Summary
| CYAN fundamental statistics | |
|---|---|
| Market cap | US$2.72m |
| Earnings (TTM) | -US$5.45m |
| Revenue (TTM) | US$23.30m |
0.1x
P/S Ratio-0.5x
P/E RatioIs CYAN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CYAN income statement (TTM) | |
|---|---|
| Revenue | US$23.30m |
| Cost of Revenue | US$17.81m |
| Gross Profit | US$5.49m |
| Other Expenses | US$10.94m |
| Earnings | -US$5.45m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.76 |
| Gross Margin | 23.55% |
| Net Profit Margin | -23.41% |
| Debt/Equity Ratio | 72.4% |
How did CYAN perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 05:44 |
| End of Day Share Price | 2024/12/26 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Cyanotech Corporation is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|